Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans

By Diamond S.   Freitag F.   Feoktistov A.   Nissan G.  

The Journal of Headache and Pain, Vol. 8, Iss. 1, 2007-02 ,pp. : 13-18

Springer Publishing Company

Access to resources Recommend Favorite

Investigation of MTHFR C677T Gene Polymorphism, Biochemical and Clinical Parameters in Turkish Migraine Patients: Association with Allodynia and Fatigue

By Bahadir Anzel   Eroz Recep   Dikici Suber  

Cellular and Molecular Neurobiology, Vol. 33, Iss. 8, 2013-11 ,pp. : 1055-1063

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence

By Finocchi Cinzia   Villani Veronica   Casucci Gerardo  

Neurological Sciences, Vol. 31, Iss. 1, 2010-06 ,pp. : 95-98

Springer Publishing Company

Access to resources Recommend Favorite

Understanding the Evidence: Evaluating the Efficacy of Migraine Medications in Clinical Practice

By Dowson A.J.   Kilminster S.   Peters M.   Lipscombe S.   Rees T.   Carter F.   Darling S.  

Headache Care, Vol. 2, Iss. 3, 2005-08 ,pp. : 133-144

Informa Healthcare

Access to resources Recommend Favorite

A Prospective Randomized Comparison of Early vs. Late Intervention During a Migraine Attack: Early Intervention Increases the Efficacy of Sumatriptan

By Scholpp Joachim   Schellenberg Ruediger   Moeckesch Beate   Banik Norbert  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 57-59

Informa Healthcare

Access to resources Recommend Favorite